NCT02385682

Brief Summary

The purpose of this registry is to evaluate long-term clinical events in patients with acute myocardial infarction who were treated with percutaneous coronary intervention. Although numerous articles have been published by using nationwide Korean myocardial infarction registries, such as the Korea Acute Myocardial Infarction Registry (KAMIR), limitation of previous registries is that these have little data beyond the first year of MI. Therefore, current registry was designed to assess long-term clinical events in patients with acute myocardial infarction. Because most of myocardial infarction patients were treated by revascularization in real world of Korea, this registry limits the inclusion criteria to patients who were treated with percutaneous coronary intervention to reduce the bias.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,748

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2004

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2015

Completed
Last Updated

April 20, 2015

Status Verified

April 1, 2015

Enrollment Period

10.9 years

First QC Date

March 5, 2015

Last Update Submit

April 16, 2015

Conditions

Long-term Major Cardiovascular EventsMyocardial InfarctionPercutaneous Coronary Intervention

Outcome Measures

Primary Outcomes (1)

  • Major adverse cardiac and cerebrovascular events

    5 years

Secondary Outcomes (11)

  • All-cause death

    5 years

  • Cardiac death

    5 years

  • Nonfatal myocardial infarction

    5 years

  • Nonfatal stroke

    5 years

  • Target lesion revascularization

    5 years

  • +6 more secondary outcomes

Study Arms (2)

ST-segment elevation AMI

ST-segment elevation acute myocardial infarction teated with percutaneous coronary intervention

Device: Percutaneous coronary intervention

Non-ST-segment elevation AMI

Non-ST-segment elevation acute myocardial infarction teated with percutaneous coronary intervention

Device: Percutaneous coronary intervention

Interventions

Percutaneous coronary interventionDEVICE

Percutaneous coronary intervention

Non-ST-segment elevation AMI

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute myocardial infarction who were treated with percutaneous coronary intervention

You may qualify if:

  • Acute myocardial infarction who were treated with percutaneous coronary intervention

You may not qualify if:

  • Acute myocardial infarction who were managed by conservative strategy
  • Acute myocardial infarction who were not treated with percutaneous coronary intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Ahn Y, Lee D, Choo EH, Choi IJ, Lim S, Lee KY, Hwang BH, Park MW, Lee JM, Park CS, Kim HY, Yoo KD, Jeon DS, Chung WS, Kim MC, Jeong MH, Ahn Y, Chang K. Association Between Bleeding and New Cancer Detection and the Prognosis in Patients With Myocardial Infarction. J Am Heart Assoc. 2022 Nov 15;11(22):e026588. doi: 10.1161/JAHA.122.026588. Epub 2022 Nov 8.

    PMID: 36346059DERIVED

  • Lim S, Choo EH, Choi IJ, Ihm SH, Kim HY, Ahn Y, Chang K, Jeong MH, Seung KB. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. J Korean Med Sci. 2019 Nov 25;34(45):e289. doi: 10.3346/jkms.2019.34.e289.

    PMID: 31760711DERIVED

  • Kim MC, Ahn Y, Cho JY, Lee KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Chang K, Seung KB. Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naive Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Korean Circ J. 2019 May;49(5):419-433. doi: 10.4070/kcj.2018.0341. Epub 2019 Feb 12.

    PMID: 30808084DERIVED

MeSH Terms

Conditions

Myocardial Infarction

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Ki-Bae Seung, MD, PhD

    Seoul St. Mary's Hospital

    PRINCIPAL INVESTIGATOR

  • Myung Ho Jeong, MD, PhD

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief of the division of cardiology

Study Record Dates

First Submitted

March 5, 2015

First Posted

March 11, 2015

Study Start

January 1, 2004

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

April 20, 2015

Record last verified: 2015-04